Good price  online

products details

Created with Pixso. Home Created with Pixso. Products Created with Pixso.
Breast Cancer Drugs
Created with Pixso. Palbociclib Capsules 100mg 21 Capsules Box CDK4 6 Inhibitor Endocrine Therapy for HR Positive HER2 Negative Breast Cancer

Palbociclib Capsules 100mg 21 Capsules Box CDK4 6 Inhibitor Endocrine Therapy for HR Positive HER2 Negative Breast Cancer

Brand Name: Sichuan Kelun Pharmaceutical Co., Ltd.
Model Number: Palbociclib KL-20223936
MOQ: Negotiable
Price: Please contact a specialist WhatsApp:55342706
Delivery Time: Negotiable
Payment Terms: Western Union,MoneyGram,T/T
Detail Information
Place of Origin:
Chengdu, Sichuan, China
Certification:
NMPA/GMP
Packaging Details:
Negotiable
Supply Ability:
Negotiable
Highlight:

CDK4 6 Inhibitor Endocrine Partner

,

HR Positive HER2 Negative Therapy

,

Advanced Breast Cancer Oral Agent

Product Description

Palbociclib 100mg x 21 Capsules

[Product Name]

Generic Name: Palbociclib

Brand Name: Pailunxin

Specification: 100mg x 21 Capsules

[Active Ingredient]

Palbociclib

[Indications]

HR+/HER2- advanced breast cancer. 100mg: first dose-reduction level. 21/7 schedule with letrozole or fulvestrant.

[Mechanism of Action]

CDK4/6 inhibitor blocking Rb phosphorylation and G1-S transition. Highly selective, reversible.

[Dosage]

100mg daily with food, 21 days on/7 off. Monitor ANC at baseline and day 15 of cycle 1.

[Adverse Reactions]

Neutropenia, fatigue, nausea, stomatitis, infections. ILD/pneumonitis, febrile neutropenia.

[Storage]

Store below 30C. Keep out of reach of children.

[Shelf Life]

24 months

Approval: H20223936